|
Orthologous residues
|
|
Rad17 (human): S656‑p, Rad17 (mouse): S657‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling, immunoprecipitation, mutation of modification site, phospho-antibody
|
|
Relevant cell lines - cell types - tissues:
293T (epithelial), A549 (pulmonary), GM847 (fibroblast), MCF-7 (breast cell)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
ATM (human)
|
genetic knockout/knockin of upstream enzyme
|
|
|
KINASE
|
ATR (human)
|
transfection of inactive enzyme
|
|
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
UV
|
|
|
|
increase
|
|
|
ionizing radiation
|
|
|
|
increase
|
|
|
hydroxyurea
|
|
|
|
increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Effect of modification (process):
cell cycle regulation
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
RAD1 (human)
|
|
Induces
|
|
|
|
|
|
Comments:
required for interaction with Rad1 and activation of the G2 checkpoint in cells damaged by ionizing radiation
|